0
Signin
countryflagCA

888-969-2592

RY 151.2 -0.6636% TD 80.12 0.9577% SHOP 83.0 1.3802% CNR 158.42 -0.9751% ENB 50.51 0.0198% CP 113.01 0.9108% BMO 119.55 0.3357% TRI 227.18 0.6334% CNQ 47.185 -0.851% BN 64.45 1.7524% ATD 82.17 -0.8208% CSU 4335.0 0.7153% BNS 62.975 -0.3402% CM 69.78 0.7508% SU 53.02 0.9136% TRP 57.81 1.1018% NGT 63.51 -3.5535% WCN 241.16 -2.9029% MFC 35.73 0.7614% BCE 45.805 0.0546%

CardioComm Solutions Inc.

Healthcare CA EKG

0.01CAD
-(-%)

Last update at 2024-07-25T15:03:00Z

Day Range

0.010.01
LowHigh

52 Week Range

0.010.02
LowHigh

Fundamentals

  • Previous Close 0.01
  • Market Cap1.51M
  • Volume3060
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.07717M
  • Revenue TTM0.94M
  • Revenue Per Share TTM0.006
  • Gross Profit TTM 0.74M
  • Diluted EPS TTM-

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -0.00246M 0.00028M -0.06361M -1.06211M -0.57706M
Minority interest - - - - -
Net income -0.00246M 0.00028M -0.06361M -1.06211M -0.57706M
Selling general administrative 0.62M 0.81M 0.77M 1.05M 1.18M
Selling and marketing expenses - - - - -
Gross profit 0.74M 0.64M 0.73M 0.69M 0.78M
Reconciled depreciation 0.03M 0.03M 0.02M 0.03M 0.00954M
Ebit -0.02248M -0.17069M -0.01822M -0.80723M -0.47580M
Ebitda 0.05M 0.06M 0.02M -0.97289M -0.50736M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -0.07375M -0.21186M -0.06123M -0.41120M -0.50331M
Other operating expenses - - - - -
Interest expense 0.02M 0.03M 0.06M 0.06M 0.06M
Tax provision - - - - -
Interest income - - - - -
Net interest income -0.02309M -0.03233M -0.05927M -0.05912M -0.06016M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 1.00M 0.68M 0.83M 0.87M 1.08M
Total operating expenses 1.07M 0.89M 0.90M 1.29M 1.58M
Cost of revenue 0.26M 0.05M 0.10M 0.18M 0.30M
Total other income expense net 0.09M 0.24M 0.06M -0.59179M -0.01359M
Discontinued operations - - - - -
Net income from continuing ops -0.00246M 0.00028M -0.06361M -1.06211M -0.57706M
Net income applicable to common shares -0.00246M -0.00246M -0.06361M -1.06211M -0.57706M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 0.28M 0.49M 0.36M 0.32M 1.09M
Intangible assets - - - - 0.00629M
Earning assets - - - - -
Other current assets - 0.02M 0.00792M 0.00830M -
Total liab 0.69M 0.91M 1.03M 1.22M 1.16M
Total stockholder equity -0.40732M -0.42338M -0.67032M -0.89581M -0.06841M
Deferred long term liab - - - - -
Other current liab 0.18M - 0.25M 0.26M 0.25M
Common stock 30.22M - 29.73M 29.68M 29.42M
Capital stock 30.22M 30.19M 29.73M 29.68M 29.42M
Retained earnings -35.15430M -35.15185M -35.15213M -35.08852M -34.02641M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.06M 0.11M 0.12M 0.08M 0.14M
Cash and equivalents - - - - -
Total current liabilities 0.69M 0.89M 1.03M 1.20M 1.16M
Current deferred revenue - - - - -
Net debt 0.27M 0.29M 0.17M 0.42M 0.46M
Short term debt - - - - 0.60M
Short long term debt 0.32M 0.40M - 0.50M 0.60M
Short long term debt total - - - - -
Other stockholder equity 4.53M - 4.75M 4.51M 4.54M
Property plant equipment 0.03M 0.05M 0.03M 0.04M 0.00279M
Total current assets 0.25M 0.43M 0.33M 0.28M 1.08M
Long term investments - - - - -
Net tangible assets -0.41485M -0.42799M -0.67383M -0.89714M -0.07470M
Short term investments - - - - -
Net receivables 0.14M 0.26M 0.11M 0.13M 0.69M
Long term debt - - 0.29M - -
Inventory 0.04M 0.05M 0.09M 0.07M 0.10M
Accounts payable 0.12M 0.16M 0.28M 0.29M 0.23M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 0.00908M
Deferred long term asset charges - - - - -
Non current assets total 0.03M 0.05M 0.03M 0.04M 0.00908M
Capital lease obligations 0.02M 0.04M 0.02M 0.04M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.01019M -0.00263M -0.01600M -0.00850M -0.01621M
Change to liabilities -0.13631M 0.00000M 0.07M 0.17M 0.09M
Total cashflows from investing activities -0.01019M -0.01019M -0.01600M -0.00850M -0.01621M
Net borrowings -0.09565M -0.09565M 0.02M -0.12261M -0.12261M
Total cash from financing activities -0.09565M -0.09565M 0.02M 0.01M 0.01M
Change to operating activities 0.00333M 0.00333M -0.00320M 0.02M 0.08M
Net income -0.00246M 0.00028M -0.06361M -1.06211M -0.57706M
Change in cash -0.05132M -0.05132M 0.04M -0.05862M -0.20874M
Begin period cash flow 0.11M 0.12M 0.08M 0.14M 0.35M
End period cash flow 0.06M 0.11M 0.12M 0.08M 0.14M
Total cash from operating activities 0.05M -0.12080M 0.04M -0.06189M -0.19253M
Issuance of capital stock - - - - 0.00000M
Depreciation 0.02M 0.03M 0.02M 0.02M 0.00115M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 0.00989M 0.00989M -0.02123M 0.03M 0.08M
Change to account receivables 0.13M 0.13M 0.02M 0.11M 0.07M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome 0.02M 0.22M 0.01M 0.64M 0.05M
Capital expenditures 0.00220M 0.00220M 0.01M 0.00587M 0.00250M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.00675M -0.37338M 0.07M 0.33M 0.36M
Stock based compensation 0.02M 0.04M 0.00660M 0.01M -
Other non cash items 0.00299M 0.19M 0.00272M 0.04M 0.01000M
Free cash flow 0.04M -0.12343M 0.02M -0.07038M -0.20874M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EKG
CardioComm Solutions Inc.		 - -% 0.01 - - 1.61 - 2.03 -278.9487
RHT
Reliq Health Technologies Inc		 - -% 0.21 - - 3.19 5.12 4.07 -10.7759
ADK
Diagnos Inc		 0.01 3.12% 0.33 - 9.75 99.08 54.61 112.33 -13.5942
NURS
Hydreight Technologies Inc		 0.005 1.69% 0.30 - - 1.33 - 1.08 -1.7505
NEWU
Newtopia Inc		 0.005 16.67% 0.04 - - 1.13 116.97 2.00 -6.0385

Reports Covered

Stock Research & News

View All

Profile

CardioComm Solutions, Inc. engages in the development of advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company is also involved in the sale of ECG recording equipment. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.

CardioComm Solutions Inc.

18 Wynford Drive, Toronto, ON, Canada, M3C 3S2

Key Executives

Name Title Year Born
Mr. Etienne Grima CHE, MSc CEO, Corp. Sec. & Director NA
Ms. Josee Bertrand CPA Chief Financial Officer NA
Mr. Simi Grosman MBA Independent Consultant & Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.